Imprimis NJOF, LLC: Drug Recall

Recall #D-0548-2024 · 05/14/2024

Class II: Risk

Recall Details

Recall Number
D-0548-2024
Classification
Class II
Product Type
Drug
Recalling Firm
Imprimis NJOF, LLC
Status
Ongoing
Date Initiated
05/14/2024
Location
Ledgewood, NJ, United States
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
4,280 boxes

Reason for Recall

Lack of Assurance of Sterility

Product Description

Prednisolone-Moxifloxacin-Bromfenac Sterile Ophthalmic Suspension, 1%, 0.5%, 0.075%, 5mL, Quantity: 20mL, Rx Only, Compounded by: Imprimis NJOF, LLC. 1705 Route 46 West, Unit 6B Ledgewood, NJ NDC 71384-310-05

Distribution Pattern

US Nationwide

Other Recalls by Imprimis NJOF, LLC

View all recalls by Imprimis NJOF, LLC →

Data from FDA openFDA enforcement reports. This site is not affiliated with or endorsed by the FDA. Recall information may be updated by the FDA at any time.